Prophylactic Surgery for Prolapse Recurrence
Trial Summary
What is the purpose of this trial?
This trial is studying whether adding an extra surgical step to a common prolapse repair surgery helps or causes more problems. It targets women undergoing surgery for vaginal prolapse. The extra step aims to provide more support but might also cause more pain.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Posterior colpoperineorrhaphy, Posterior colporrhaphy, Posterior vaginal wall repair, Colpoperineorrhaphy for prolapse recurrence?
Research shows that posterior colporrhaphy, a type of surgery to repair the back wall of the vagina, can significantly improve symptoms like vaginal lump sensation and constipation in patients with posterior vaginal prolapse. Additionally, studies suggest that using surgical mesh in these procedures may reduce the chance of prolapse coming back.12345
Is prophylactic surgery for prolapse recurrence generally safe for humans?
How does prophylactic surgery for prolapse recurrence differ from other treatments?
Prophylactic surgery for prolapse recurrence may involve the use of non-absorbable polypropylene mesh, which is different from traditional methods like posterior colporrhaphy that often involve stitching muscles together. This mesh approach aims to provide stronger support and potentially reduce the chance of prolapse coming back, although it may carry risks like infection or erosion.234910
Research Team
Julia Geynisman-Tan, MD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for women over 18 with symptomatic prolapse (stage II or greater) who are undergoing a specific minimally-invasive surgery using Restorelle mesh and have a genital opening of at least 4cm when straining. Participants must speak English or Spanish. Women who are pregnant, had previous prolapse surgery, suffer from inflammatory bowel disease, have certain pelvic floor muscle conditions, or experience pain during intercourse cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo sacrocolpopexy with or without posterior colpoperineorrhaphy
Postoperative Recovery
Participants are monitored for postoperative pain, pain medication use, and blood loss
Follow-up
Participants are monitored for prolapse recurrence, defecatory dysfunction, and dyspareunia
Treatment Details
Interventions
- Posterior colpoperineorrhaphy (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
University of Kansas
Collaborator
Lynne A. Bui
University of Kansas
Chief Medical Officer since 2017
MD from the David Geffen UCLA School of Medicine, BA in Molecular and Cell Biology from University of California, Berkeley
Randy Milby
University of Kansas
Chief Executive Officer since 2017
BS in Pharmacy from The University of Kansas, MBA in Finance/Marketing from Washington University in St. Louis – Olin Business School
The Institute of Pelvic Medicine & Reconstructive Surgery, Allentown, Pennsylvania
Collaborator